On ECHEMI
Home > Drugs > Gefitinib Registered Holders
Gefitinib structure

Gefitinib structure

Gefitinib

Light-Yellow Crystalline PowderGefitinib was introduced in Japan as a daily oral monotherapy for the treatment of inoperable or recurrent non-small cell lung cancers (NSCLC). This anilinoquinazoline derivative can be synthesized in 6 steps starting from 6,7-dimethoxyquinazolin-4(3H)-one by successive monodemethylationlacetylation of the 6-hydroxy-group followed by chlorination and reaction with 3-chloro-4-fluoroaniline, finally deacetylation and alkylation with 3-(4-morpholinyl)propylbromi

Find 37 Related Holders

CDYMAX (INDIA) PHARMA PRIVATE LTD
United States United States

API Registration Country

API Active
YABAO PHARMACEUTICAL GROUP CO LTD
United States United States

API Registration Country

API Active
HETERO LABS LTD
United States United States

API Registration Country

API Active
ALEMBIC PHARMACEUTICALS LTD
United States United States

API Registration Country

API Active
NATCO PHARMA LTD
Brazil Brazil

API Registration Country

API Active
  • Country:

    Brazil Brazil
  • Address:

    ROAD NR 2, EXTERIOR - EX
Synthon B.V.
Netherlands Netherlands

API Registration Country

API Active
  • Country:

    Netherlands Netherlands
  • Address:

    Microweg 22, 6545CM Nijmegen
  • Email:

NATCO PHARMA LIMITED
India India

API Registration Country

API Active
  • Founded in:

    1981-09-19 00:00:00
  • Country:

    India India
  • Address:

    Natco House , Road No.2, Banjara hills NA Hyderabad Hyderabad TG 500034 IN
  • Registered Funds:

    358.2 million INR
  • Email:

CIPLA LTD.
Brazil Brazil

API Registration Country

API Active
  • Country:

    Brazil Brazil
  • Address:

    VIKHROLI, EXTERIOR - EX
China CHINO PHARMA Ltd
China China

API Registration Country

API Active
  • Founded in:

    2021-08-10
  • Country:

    China China
  • Address:

    Room 402, No. 54, Lane 1277, Zhuanxing East Road, Minhang District, Shanghai
  • Tax NO.:

    91310112MA1GF2KC6D
  • Registered Funds:

    1 million yuan
  • Website:

  • Email:

Shandong Newtime Pharmaceutical Co., Ltd.
China China

API Registration Country

API Active
  • Founded in:

    2001-03-30
  • Country:

    China China
  • Address:

    No. 1 North Outer Ring Road, Fei County, Shandong
  • Tax NO.:

    9137130072755352X1
  • Registered Funds:

    358.238 million yuan
  • Website:

  • Email:

Recommended Suppliers of Gefitinib
View 211 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.